Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow.
about
Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody.Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control regionStrain variation in the frequency of Abelson murine leukemia virus-transformed fetal liver pre-B cells bearing complete immunoglobulin heavy chain rearrangements.Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells.Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool.B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinase.BTK Signaling in B Cell Differentiation and Autoimmunity.Definition of the gene loci in X-linked immunodeficiencies.Bruton's tyrosine kinase is a key regulator in B-cell development.X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene.xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.
P2860
Q33570660-A908E283-43C2-4209-8119-F4D2F11FB4F2Q33593017-D1D53DEA-29EA-4F35-A14B-6EAAEAE4E306Q35908626-6FB363CF-7D35-4219-AD43-BDB56255E827Q35957766-D9A5E4AA-BD51-4145-BF37-E42E62019363Q36355690-3366A167-0DE5-4B17-B666-2AE37FDFCEF3Q36363807-3A2ECC7A-C357-468E-BC24-AAA8B3EF0D03Q36380979-1C9B07FC-02E4-408E-AED8-ACFC5FD08E39Q36400629-AE0888D4-91E8-4778-BAB3-86E69E36ACD4Q36675682-0620B411-768E-44A9-AD30-A6A467D1EED1Q37737830-8BD1504A-577D-40ED-A1B6-8BDE8964A173Q38581000-FA45B5D7-CB19-431A-BE01-AD5B3A112823Q39545257-ADA1409B-9350-4310-BBB9-34FC490769EBQ40694860-79E511D4-D44C-418D-801A-27FD5EC4A4BEQ40694880-42F7F89A-E63F-4AB8-A502-E33F363D4C17Q43805222-E16EB976-A58A-428D-A937-FE3570FDFA74Q45870581-5E8FCF96-7761-4A05-AB20-D9084593D236
P2860
Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Development of B lymphocytes i ...... tial formation in bone marrow.
@ast
Development of B lymphocytes i ...... tial formation in bone marrow.
@en
type
label
Development of B lymphocytes i ...... tial formation in bone marrow.
@ast
Development of B lymphocytes i ...... tial formation in bone marrow.
@en
prefLabel
Development of B lymphocytes i ...... tial formation in bone marrow.
@ast
Development of B lymphocytes i ...... tial formation in bone marrow.
@en
P2093
P2860
P356
P1476
Development of B lymphocytes i ...... tial formation in bone marrow.
@en
P2093
Forrester LM
Micklem HS
P2860
P304
P356
10.1084/JEM.165.4.949
P407
P577
1987-04-01T00:00:00Z